Deerfield Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-52,257
Closed -$545K 141
2025
Q4
$545K Buy
+52,257
New +$524K 0.01% 129
2025
Q3
Sell
-888,950
Closed -$11.6M 168
2025
Q2
$11.6M Buy
888,950
+496,618
+127% +$7.47M 0.21% 63
2025
Q1
$9.91M Buy
+392,332
New +$11.7M 0.2% 70
2024
Q3
Sell
-8,942
Closed -$538K 616
2024
Q2
$538K Buy
8,942
+757
+9% +$43.3K 0.01% 249
2024
Q1
$422K Buy
+8,185
New +$402K 0.01% 175
2021
Q4
Sell
-900,000
Closed -$11.4M 139
2021
Q3
$11.4M Buy
+900,000
New +$12.4M 0.22% 87

Other funds holding RXST

Deerfield Management's RXST Position: Q1 2026 in Review

Deerfield Management sold out of RxSight (RXST) in Q1 2026, closing a stake of 52,257 shares — an estimated $545K sold.

Deerfield Management first reported a position in RXST in Q3 2021 and held it in 6 quarters. The position peaked at $11.6M in Q2 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Deerfield Management reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
  • Deerfield Management sold 52,257 RxSight shares in Q1 2026, an estimated $545K.
  • Deerfield Management first reported a position in RxSight in Q3 2021 and held it in 6 quarters.
  • Deerfield Management's RxSight position peaked at $11.6M in Q2 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.